SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference51 articles.
1. Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: competing forces in an era of heightened focus on care quality?;von Itzstein;PLoS One.,2020
2. Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial;Suzuki;J Thorac Cardiovasc Surg.,2019
3. The society of thoracic surgeons composite score rating for pulmonary resection for lung cancer;Broderick;Ann Thorac Surg.,2020
4. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503);Altorki;Lancet Respir Med.,2018
5. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Brunelli;Chest,2013
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic;Lung Cancer Management;2024-07-03
2. Hybrid approaches to pulmonary metastasectomy: a narrative review;Video-Assisted Thoracic Surgery;2024-06
3. Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network;Clinical Lung Cancer;2023-12
4. COVID-19 and lung cancer;Pathologica;2023-10
5. Stereotactic ablative radiotherapy before resection to avoid delay for early‐stage lung cancer or oligometastases during the COVID‐19 pandemic: Pathologic outcomes from the SABR‐BRIDGE protocol;Cancer;2023-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3